講演情報
[F2-70]Antigenic Variation Among Dengue Virus Genotypes Impacts Antibody-Mediated Neutralization and Antibody-Dependent Enhancement in Patients and Vaccinees
*Jean Claude Balingit1, Motoharu Abe2, Ryosuke Suzuki3, Dalouny Xayavong4, Mya Myat Ngwe Tun1,4,5, Mami Matsuda3, Yuki Takamatsu1,4, Corazon Buerano1, Kengo Sonoda2, Kouichi Morita1,4,6 (1. Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University (Japan), 2. CMC Development Division, KM Biologics Co., Ltd. (Japan), 3. Department of Virology II, National Institute of Infectious Diseases (Japan), 4. Department of Virology, Institute of Tropical Medicine, Nagasaki University (Japan), 5. Center for Vaccine and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University (Japan), 6. DEJIMA Infectious Disease Research Alliance, Nagasaki University (Japan))
